科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/29 | 4,295 | 4,333 | 4,241 | 4,323 | +10 | +0.2% | 147,500 |
| 2024/11/28 | 4,299 | 4,338 | 4,287 | 4,313 | +23 | +0.5% | 142,800 |
| 2024/11/27 | 4,307 | 4,353 | 4,259 | 4,290 | -40 | -0.9% | 263,800 |
| 2024/11/26 | 4,414 | 4,416 | 4,308 | 4,330 | -52 | -1.2% | 280,000 |
| 2024/11/25 | 4,478 | 4,490 | 4,381 | 4,382 | -79 | -1.8% | 221,400 |
| 2024/11/22 | 4,453 | 4,498 | 4,417 | 4,461 | +23 | +0.5% | 209,000 |
| 2024/11/21 | 4,448 | 4,542 | 4,416 | 4,438 | +3 | +0.1% | 245,100 |
| 2024/11/20 | 4,486 | 4,497 | 4,421 | 4,435 | -67 | -1.5% | 205,800 |
| 2024/11/19 | 4,530 | 4,544 | 4,442 | 4,502 | -59 | -1.3% | 253,000 |
| 2024/11/18 | 4,395 | 4,577 | 4,373 | 4,561 | +181 | +4.1% | 392,300 |
| 2024/11/15 | 4,386 | 4,398 | 4,316 | 4,380 | +4 | +0.1% | 257,000 |
| 2024/11/14 | 4,369 | 4,420 | 4,310 | 4,376 | +13 | +0.3% | 289,000 |
| 2024/11/13 | 4,330 | 4,448 | 4,302 | 4,363 | +53 | +1.2% | 451,000 |
| 2024/11/12 | 4,093 | 4,318 | 4,093 | 4,310 | +268 | +6.6% | 636,800 |
| 2024/11/11 | 3,939 | 4,075 | 3,935 | 4,042 | +173 | +4.5% | 378,900 |
| 2024/11/08 | 3,906 | 3,909 | 3,751 | 3,869 | -20 | -0.5% | 164,500 |
| 2024/11/07 | 3,885 | 3,919 | 3,883 | 3,889 | +27 | +0.7% | 89,000 |
| 2024/11/06 | 3,890 | 3,905 | 3,861 | 3,862 | -31 | -0.8% | 101,900 |
| 2024/11/05 | 3,885 | 3,901 | 3,873 | 3,893 | +8 | +0.2% | 73,800 |
| 2024/11/01 | 3,900 | 3,918 | 3,871 | 3,885 | -20 | -0.5% | 93,400 |
| 2024/10/31 | 3,922 | 3,933 | 3,885 | 3,905 | +7 | +0.2% | 98,700 |
| 2024/10/30 | 3,925 | 3,945 | 3,891 | 3,898 | -26 | -0.7% | 147,100 |
| 2024/10/29 | 3,887 | 3,953 | 3,887 | 3,924 | +20 | +0.5% | 60,400 |
| 2024/10/28 | 3,892 | 3,912 | 3,874 | 3,904 | +4 | +0.1% | 84,400 |
| 2024/10/25 | 3,901 | 3,908 | 3,870 | 3,900 | +15 | +0.4% | 160,800 |
| 2024/10/24 | 3,852 | 3,899 | 3,840 | 3,885 | +31 | +0.8% | 79,800 |
| 2024/10/23 | 3,848 | 3,892 | 3,840 | 3,854 | -11 | -0.3% | 93,200 |
| 2024/10/22 | 3,870 | 3,872 | 3,833 | 3,865 | -4 | -0.1% | 88,100 |
| 2024/10/21 | 3,861 | 3,871 | 3,838 | 3,869 | +5 | +0.1% | 99,900 |
| 2024/10/18 | 3,889 | 3,922 | 3,853 | 3,864 | +13 | +0.3% | 95,900 |
| 2024/10/17 | 3,842 | 3,859 | 3,827 | 3,851 | +17 | +0.4% | 84,700 |
| 2024/10/16 | 3,869 | 3,907 | 3,834 | 3,834 | -72 | -1.8% | 73,100 |
| 2024/10/15 | 3,881 | 3,907 | 3,865 | 3,906 | +25 | +0.6% | 109,200 |
| 2024/10/11 | 3,900 | 3,905 | 3,873 | 3,881 | -19 | -0.5% | 84,900 |
| 2024/10/10 | 3,880 | 3,914 | 3,880 | 3,900 | -3 | -0.1% | 60,700 |
| 2024/10/09 | 3,885 | 3,911 | 3,874 | 3,903 | +36 | +0.9% | 87,600 |
| 2024/10/08 | 3,850 | 3,891 | 3,839 | 3,867 | -12 | -0.3% | 100,900 |
| 2024/10/07 | 3,890 | 3,890 | 3,851 | 3,879 | +19 | +0.5% | 112,500 |
| 2024/10/04 | 3,840 | 3,875 | 3,840 | 3,860 | -8 | -0.2% | 88,000 |
| 2024/10/03 | 3,863 | 3,879 | 3,831 | 3,868 | +52 | +1.4% | 126,000 |
| 2024/10/02 | 3,827 | 3,870 | 3,812 | 3,816 | -19 | -0.5% | 83,300 |
| 2024/10/01 | 3,823 | 3,846 | 3,776 | 3,835 | +12 | +0.3% | 82,500 |
| 2024/09/30 | 3,779 | 3,837 | 3,770 | 3,823 | -26 | -0.7% | 94,200 |
| 2024/09/27 | 3,880 | 3,895 | 3,840 | 3,849 | -158 | -3.9% | 144,400 |
| 2024/09/26 | 3,980 | 4,007 | 3,968 | 4,007 | +47 | +1.2% | 139,700 |
| 2024/09/25 | 3,916 | 3,970 | 3,899 | 3,960 | +43 | +1.1% | 93,100 |
| 2024/09/24 | 3,949 | 3,957 | 3,908 | 3,917 | -19 | -0.5% | 108,200 |
| 2024/09/20 | 3,904 | 3,960 | 3,904 | 3,936 | +35 | +0.9% | 140,900 |
| 2024/09/19 | 3,910 | 3,952 | 3,901 | 3,901 | -14 | -0.4% | 84,900 |
| 2024/09/18 | 3,910 | 3,946 | 3,882 | 3,915 | -8 | -0.2% | 81,800 |
101～
150
件表示中 / 3691件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 406,300円 | +30.5% | +111.0% | 4.68% | 11.45倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ペプチド | 201,200円 | +5.0% | +1.5% | 0.00% | 17.27倍 | 4.59倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 205,000円 | +4.0% | +25.4% | 2.59% | 8.96倍 | 1.18倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 380,000円 | +14.5% | -2.3% | 2.37% | 13.90倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 240,800円 | - | - | 0.00% | - | 111.53倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
